Treatment of congenital cytomegalovirus infection: Implications for future therapeutic strategies

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 5, 2009, Pages 862-867

  Nassetta, Lauren ^a   Kimberlin, David ^a   Whitley, Richard ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

CMV; Congenital infection; Therapy

Indexed keywords

BENZIMIDAVIR; GANCICLOVIR; VALGANCICLOVIR;

ANTIVIRAL THERAPY; CLINICAL TRIAL; CONGENITAL INFECTION; CONTROLLED CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; HEARING IMPAIRMENT; HEARING LOSS; HEPATOMEGALY; HUMAN; JAUNDICE; MICROCEPHALY; NEUTROPENIA; PETECHIA; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SPLENOMEGALY; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HEARING LOSS, CENTRAL; HUMANS; INFANT; NEUTROPENIA; UNITED STATES;

EID: 64649089962     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp083     Document Type: Review

References (67)

1. Stagno S, Britt W. Cytomegalovirus infections. In: Remington J, Klein J, Wilson C et al., eds. Infectious Diseases of the Fetus and Newborn Infant, Sixth Edition. Philadelphia: Elsevier, 2006; 739-81.
2. Ribbert H. Uber protozoenartigen Zellen in der Nireeines syphilitiscen Neugeboren und in der Parotis von Kindren. Zentralbl Allg Pathol 1904; 15: 945-8.
3. Lowenstein C. Uber protozoenartigen Gebilden in den Organen von Dindern. Zentralbl Allg Pathol 1907; 18: 513-8.
4. Sinzger C, Grefte A, Plachter B et al. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995; 76: 741-50.
5. Plachter B, Sinzger C, Jahn G. Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res 1996; 46 195-261.
6. Sinzger C, Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 1996; 39: 302-19.
7. Halwachs-Baumann G, Wilders-Truschnig M, Desoye G et al. Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus. J Virol 1998; 72: 7598-602.
8. Hemmings DG, Kilani R, Nykiforuk C et al. Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol 1998; 72: 4970-9.
9. Fisher S, Genbacev O, Maidji E et al. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero implications for transmission and pathogenesis. J Virol 2000; 74: 6808-20.
10. Hahn G, Baldanti F, Gallina A et al. Human cytomegalovirus UL131-128 genes are indispensible for virus growth in endothelial cells and virus transfer to leucocytes. J Virol 2004; 78: 10023-33.
11. Weller TH. The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations. N Engl J Med 1971; 285: 203-14.
12. Krech U, Jung M, Jung F. Cytomegalovirus Infections of Man. Basel: Karger, 1971.
13. Gold E, Nankervis GA. Cytomegalovirus. In: Evans AS, ed. Viral Infections of Humans: Epidemiology and Control. New York: Plenum, 1982; 167-86.
14. Staras SAS, Dollard SC, Radford KW et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43: 1143-51.
15. Stagno S, Pass RF, Cloud G et al. Primary cytomegalovirus infection in pregnancy: Incidence, transmission to fetus and clinical outcome. JAMA 1986; 256: 1904-8.
16. Hayes K, Danks DM, Gibas H et al. Cytomegalovirus in human milk. N Engl J Med 1972; 287: 177-8.
17. Lang DJ, Krummer JF. Cytomegalovirus in semen: Observations in selected populations. J Infect Dis 1975; 132: 472-3.
18. Reynolds DW, Stagno S, Hosty TS et al. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973; 289: 1-5.
19. Stagno S, Reynolds DE, Pass RF et al. Breast milk and the risk of cytomegalovirus infection. N Engl J Med 1980; 302: 1073-6.
20. Bowden RA. Cytomegalovirus infection in transplant patients: Methods of prevention of primary cytomegalovirus. Transplant Proc 1991; 23 136-8.
21. Taber LH, Frank AL, Yow MD et al. Acquisition of cytomegaloviral infections in families with young children: A serological study. J Infect Dis 1985; 151: 948-52.
22. Schopfer K, Lauber E, Krech U. Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child 1978; 53: 536-9.
23. Stagno S, Reynolds DW, Huang ES et al. Congenital cytomegalovirus infection: Occurrence in an immune population. N Engl J Med 1977; 296: 1254-8.
24. Boppana SB, Rivera LB, Fowler KB et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptual immunity. N Engl J Med 2001; 344: 1366-71.
25. Stagno S, Pass RF, Dworsky ME et al. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 1982; 25: 563-76.
26. Pass RF, August AM, Dworsky M et al. Cytomegalovirus infection in a day care center. N Engl J Med 1982; 307: 477-9.
27. Adler SP, Wilson MS, Lawrence LT. Cytomegalovirus transmission among children attending a day care center. Pediatr Res 1985; 19: 285A (abstract).
28. Murph JR, Bale JF, Perlman S et al. The prevalence of cytomegalovirus infection in a Midwest day care center. Pediatr Res 1985; 19: 205S (abstract).
29. Adler SP. The molecular epidemiology of cytomegalovirus transmission among children attending a day care center. J Infect Dis 1985; 152: 760-8.
30. Hutto C, Ricks R, Garvie M et al. Epidemiology of cytomegalovirus infections in young children: Day care vs. home care. Pediatr Infect Dis 1985; 4: 149-52.
31. Pass RF, Little EA, Stagno S et al. Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med 1987; 316: 1366-70.
32. Hutto C, Little A, Ricks R et al. Isolation of cytomegalovirus from toys and hands in a day care center. J Infect Dis 1986; 154: 527-30.
33. Faix RG. Survival of cytomegalovirus on environmental surfaces. J Pediatr 1985; 106: 649-52.
34. Stagno S. Breastfeeding and the transmission of cytomegalovirus infections. Ital J Pediatr 2002; 28: 275-80.
35. Kreel I, Zaroff LI, Canter JW et al. A syndrome following total body perfusion. Surg Gynecol Obstet 1960; 111: 317-21.
36. Seaman AJ, Starr A. Febrile postcardiotomy lymphocytic splenomegaly: A new entity. Ann Surg 1962; 156: 956-60.
37. Armstrong JA, Tarr GC, Youngblood LA et al. Cytomegalovirus infection in children undergoing open-heart surgery. Yale J Biol Med 1976; 49: 83-91.
38. Prince AM, Szmuness W, Millian SJ et al. A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med 1971; 284: 1125-31.
39. Stevens DP, Barker LF, Ketcham AS et al. Asymptomatic cytomegalovirus infection following blood transfusion in tumor surgery. JAMA 1970; 211: 1341-4.
40. Kaariainen L, Klemola E, Palohelmo J. Rise of cytornegalovirus antibodies in an infectious mononucleosis-like syndrome after transfusion. BMJ 1966; 1: 1270-2.
41. Neiman PE, Reeves W, R6y G et al. A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis 1977; 1-36: 754-67.
42. Winston DJ, Gale RP, Meyer DV et al. Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 1979; 58: 1-31.
43. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years' experience. Rev Infect Dis 1982; 4: 1119-32.
44. Fowler KB, McCollister FP, Dahle AJ et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130: 624-30.
45. Harris S, Ahtfors K, Ivarsson S et al. Congenital cytomegalovirus infection and sensorineural hearing loss. Ear Hear 1984; 5: 352-5.
46. Williamson WD, Percy AK, Yow MD et al. Asymptomatic congenital cytomegalovirus infection. Audiologic, neuroradiologic and neuro-developmental abnormalities during the first- year. Am J Dis Child 1990; 144: 1365-8.
47. Hicks T, Fowler K, Richardson M et al. Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr 1993; 123 779-82.
48. Boppana SB, Pass RF, Britt WJ et al. Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality. Pediatr Infect Dis J 1992; 11: 93-9.
49. Weller TH, Hanshaw JB. Virologic and clinical observations on cytomegalic inclusion disbase. N Engl J Med 1962; 266: 1233-44.
50. Stagno S, Pass RF, Dworsky ME et al. Congenital and perinatal cytomegalovirus infections. Semin Perinatol 1983; 7: 31-42.
51. Hanshaw JB, Dudgeon JA, eds. Viral Diseases of the Fetus and Newborn Philadelphia: WB Saunders, 1978.
52. Osborn JE, Shahidi NT. Thrombocylopenia in murine cytomegalovirus infection. J Lab Clin Med 1973; 81: 53-63.
53. Anderson KS, Amos CS, Boppana S et al. Ocular abnormalities in congenital cytomegalovirus infection. J Am Oplom Assoc 1996; 67 273-8.
54. Stagno S, Reynolds DW, Amos CS et al. Auditory and visual defects resulting from symptomatic and subclnical congenital cytomegaloviral and toxoplasma infections. Pediatrics 1977; 59: 669-78.
55. Boppana SB, Fowler KB, Vaid Y et al. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997; 99: 404-14.
56. Dahle AJ, McCollister FP, Stagno S et al. Progressive hearing impairment in children with congenital cytomegalovirus infection. J Speech Hear Disord 1979; 44: 220-9.
57. Dahle AJ, Fowler KB, Wright JD et al. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000; 11: 283-90.
58. Bale JF, Bray PF, Bell WE. Neuroradiographic abnormalities in congenital cytomegalovirus infection. Pediatr Neurol 1985; 1: 42-7.
59. Perlman JM, Argyle C. Lethal cytomegalovirus infection in preterm infants: Clinical, radiological, and neuropathological findings. Ann Neurol 1992; 31: 64-8.
60. Boesch C, Issakainen J, Kewitz G et al. Magnetic resonance imaging of the brain in congenital cytomegalovirus infection. Pediatr Radiol 1989; 19: 91-3.
61. Whitley RJ, Cloud G, Gruber W et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study. J Infect Dis 1997; 53: 1080-6.
62. Kimberlin DW, Lin CY, Sanchez PJ et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial. J Pediatr 2003; 143: 16-25.
63. American Academy of Pediatrics. Cytomegalovirus infection. In: Pickering LK, ed. 2006 Red Book: Report of the Committee on Infectious Disease, Twenty-seventh Edition. Elk Grove Village, IL: American Academy of Pediatrics, 2006; 273-7.
64. Acosta EP, Brundage RC, King JR et al. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther 2007; 81: 867-72.
65. Kimberlin DW, Acosta EP, Sanchez PJ et al. Pharmacokinetic and pharmacodynamic assessment of oral valgancidovir in the treatment of symptomatic congenital cytomegalavirus disease. J Infect Dis 2008; 197: 836-45.
66. Trofe J, Pote L, Wade E et al. Maribavir: A novel antiviral agent with activity against cytomegalovirus. Ann Pharmacother 2008; 42: 1447-57.
67. Mocarski ES, Shenk T, Pass RF. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM et al. eds. Virology 5th edn. Philadelphia: Lippincott Williams and Wilkins, 2007; 2701-72.